ENGLISH
日本語
Top
About
Team
Portfolio
Contact
32626111a.jpg

Past News

Axil Capital's News

Next

More Axil Capital's Recent News

Jul 10, 2021​​

We moved to our new office in Minato-ku, Nishi-shimbashi.

Blank-Small.png
Go
Jun 22, 2021

Our portfolio company, Perseus Proteomics (4882), successfully completed its IPO listing on the Tokyo Stock Exchange Mothers Board.

PPMX-Small.png
Go
Oct 6, 2020

Our portfolio company, C4 Therapeutics (CCCC), successfully completed its IPO listing on the NASDAQ exchange.

C4-small.png
Go
Oct 3, 2019

Our portfolio company, Frequency Therapeutics (FREQ), successfully completed its IPO listing on the NASDAQ exchange.

frequency-Small.png
Go
 

Portfolio Companies' News

Next

More Portfolio Companies' Recent News

Sep 7, 2021

United Immunity completed Series B round.

Go
Jan 14, 2021

United Immunity has entered into a joint research agreement with Xyphos/Astellas on cancer immunotherapy program.

Next
Mar 31, 2021

United Immunity completed Series A2 round.

Next
...

AIBIOS is working on three active programs to resolve unmet medical needs.

Next
 
Axil Capital-07.png

Axil Capital Advisors K.K.

Nittochi Nishi-shinbashi Bldg. 7F

1-11-4 Nishi-shinbashi

Minato-ku, Tokyo 105-0003, JAPAN

© Axil Capital All Rights Reserved